613 related articles for article (PubMed ID: 26988591)
1. Mesenchymal Stem Cells Attenuate NADPH Oxidase-Dependent High Mobility Group Box 1 Production and Inhibit Abdominal Aortic Aneurysms.
Sharma AK; Salmon MD; Lu G; Su G; Pope NH; Smith JR; Weiss ML; Upchurch GR
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):908-18. PubMed ID: 26988591
[TBL] [Abstract][Full Text] [Related]
2. Experimental abdominal aortic aneurysm formation is mediated by IL-17 and attenuated by mesenchymal stem cell treatment.
Sharma AK; Lu G; Jester A; Johnston WF; Zhao Y; Hajzus VA; Saadatzadeh MR; Su G; Bhamidipati CM; Mehta GS; Kron IL; Laubach VE; Murphy MP; Ailawadi G; Upchurch GR
Circulation; 2012 Sep; 126(11 Suppl 1):S38-45. PubMed ID: 22965992
[TBL] [Abstract][Full Text] [Related]
3. NADPH oxidase deficiency exacerbates angiotensin II-induced abdominal aortic aneurysms in mice.
Kigawa Y; Miyazaki T; Lei XF; Nakamachi T; Oguchi T; Kim-Kaneyama JR; Taniyama M; Tsunawaki S; Shioda S; Miyazaki A
Arterioscler Thromb Vasc Biol; 2014 Nov; 34(11):2413-20. PubMed ID: 25189573
[TBL] [Abstract][Full Text] [Related]
4. Deficiency of γδT cells protects against abdominal aortic aneurysms by regulating phosphoinositide 3-kinase/AKT signaling.
Zhang S; Kan X; Li Y; Li P; Zhang C; Li G; Du J; You B
J Vasc Surg; 2018 Mar; 67(3):899-908.e1. PubMed ID: 28024851
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor β neutralization finely tunes macrophage phenotype in elastase-induced abdominal aortic aneurysm and is associated with an increase of arginase 1 expression in the aorta.
Raffort J; Lareyre F; Clément M; Moratal C; Jean-Baptiste E; Hassen-Khodja R; Burel-Vandenbos F; Bruneval P; Chinetti G; Mallat Z
J Vasc Surg; 2019 Aug; 70(2):588-598.e2. PubMed ID: 30792060
[TBL] [Abstract][Full Text] [Related]
6. High-mobility group box 1 protein blockade suppresses development of abdominal aortic aneurysm.
Kohno T; Anzai T; Kaneko H; Sugano Y; Shimizu H; Shimoda M; Miyasho T; Okamoto M; Yokota H; Yamada S; Yoshikawa T; Okada Y; Yozu R; Ogawa S; Fukuda K
J Cardiol; 2012 May; 59(3):299-306. PubMed ID: 22365948
[TBL] [Abstract][Full Text] [Related]
7. Resolvin D1 decreases abdominal aortic aneurysm formation by inhibiting NETosis in a mouse model.
Spinosa M; Su G; Salmon MD; Lu G; Cullen JM; Fashandi AZ; Hawkins RB; Montgomery W; Meher AK; Conte MS; Sharma AK; Ailawadi G; Upchurch GR
J Vasc Surg; 2018 Dec; 68(6S):93S-103S. PubMed ID: 30470363
[TBL] [Abstract][Full Text] [Related]
8. Genetic Ablation of MicroRNA-33 Attenuates Inflammation and Abdominal Aortic Aneurysm Formation via Several Anti-Inflammatory Pathways.
Nakao T; Horie T; Baba O; Nishiga M; Nishino T; Izuhara M; Kuwabara Y; Nishi H; Usami S; Nakazeki F; Ide Y; Koyama S; Kimura M; Sowa N; Ohno S; Aoki H; Hasegawa K; Sakamoto K; Minatoya K; Kimura T; Ono K
Arterioscler Thromb Vasc Biol; 2017 Nov; 37(11):2161-2170. PubMed ID: 28882868
[TBL] [Abstract][Full Text] [Related]
9. Genetic and pharmacologic disruption of interleukin-1β signaling inhibits experimental aortic aneurysm formation.
Johnston WF; Salmon M; Su G; Lu G; Stone ML; Zhao Y; Owens GK; Upchurch GR; Ailawadi G
Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):294-304. PubMed ID: 23288154
[TBL] [Abstract][Full Text] [Related]
10. Lipocalin-2 deficiency or blockade protects against aortic abdominal aneurysm development in mice.
Tarín C; Fernandez-Garcia CE; Burillo E; Pastor-Vargas C; Llamas-Granda P; Castejón B; Ramos-Mozo P; Torres-Fonseca MM; Berger T; Mak TW; Egido J; Blanco-Colio LM; Martín-Ventura JL
Cardiovasc Res; 2016 Aug; 111(3):262-73. PubMed ID: 27229458
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic blockade and genetic deletion of androgen receptor attenuates aortic aneurysm formation.
Davis JP; Salmon M; Pope NH; Lu G; Su G; Meher A; Ailawadi G; Upchurch GR
J Vasc Surg; 2016 Jun; 63(6):1602-1612.e2. PubMed ID: 26817611
[TBL] [Abstract][Full Text] [Related]
12. Resolution of inflammation via RvD1/FPR2 signaling mitigates Nox2 activation and ferroptosis of macrophages in experimental abdominal aortic aneurysms.
Filiberto AC; Ladd Z; Leroy V; Su G; Elder CT; Pruitt EY; Hensley SE; Lu G; Hartman JB; Zarrinpar A; Sharma AK; Upchurch GR
FASEB J; 2022 Nov; 36(11):e22579. PubMed ID: 36183323
[TBL] [Abstract][Full Text] [Related]
13. Aromatase is required for female abdominal aortic aneurysm protection.
Johnston WF; Salmon M; Su G; Lu G; Ailawadi G; Upchurch GR
J Vasc Surg; 2015 Jun; 61(6):1565-74.e1-4. PubMed ID: 24582702
[TBL] [Abstract][Full Text] [Related]
14. Intermedin1-53 Attenuates Abdominal Aortic Aneurysm by Inhibiting Oxidative Stress.
Lu WW; Jia LX; Ni XQ; Zhao L; Chang JR; Zhang JS; Hou YL; Zhu Y; Guan YF; Yu YR; Du J; Tang CS; Qi YF
Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2176-2190. PubMed ID: 27634835
[TBL] [Abstract][Full Text] [Related]
15. Zoledronate attenuates angiotensin II-induced abdominal aortic aneurysm through inactivation of Rho/ROCK-dependent JNK and NF-κB pathway.
Tsai SH; Huang PH; Peng YJ; Chang WC; Tsai HY; Leu HB; Chen JW; Lin SJ
Cardiovasc Res; 2013 Dec; 100(3):501-10. PubMed ID: 24225494
[TBL] [Abstract][Full Text] [Related]
16. Receptor-interacting protein kinase 3 contributes to abdominal aortic aneurysms via smooth muscle cell necrosis and inflammation.
Wang Q; Liu Z; Ren J; Morgan S; Assa C; Liu B
Circ Res; 2015 Feb; 116(4):600-11. PubMed ID: 25563840
[TBL] [Abstract][Full Text] [Related]
17. Cigarette smoking increases aortic dilatation without affecting matrix metalloproteinase-9 and -12 expression in a modified mouse model of aneurysm formation.
Bergoeing MP; Arif B; Hackmann AE; Ennis TL; Thompson RW; Curci JA
J Vasc Surg; 2007 Jun; 45(6):1217-1227. PubMed ID: 17398058
[TBL] [Abstract][Full Text] [Related]
18. Allergic Lung Inflammation Aggravates Angiotensin II-Induced Abdominal Aortic Aneurysms in Mice.
Liu CL; Wang Y; Liao M; Wemmelund H; Ren J; Fernandes C; Zhou Y; Sukhova GK; Lindholt JS; Johnsen SP; Zhang JY; Cheng X; Huang X; Daugherty A; Levy BD; Libby P; Shi GP
Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):69-77. PubMed ID: 26543094
[TBL] [Abstract][Full Text] [Related]
19. Inhibition or deletion of angiotensin II type 1 receptor suppresses elastase-induced experimental abdominal aortic aneurysms.
Xuan H; Xu B; Wang W; Tanaka H; Fujimura N; Miyata M; Michie SA; Dalman RL
J Vasc Surg; 2018 Feb; 67(2):573-584.e2. PubMed ID: 28434702
[TBL] [Abstract][Full Text] [Related]
20. Fcγ receptor activation mediates vascular inflammation and abdominal aortic aneurysm development.
Lopez-Sanz L; Bernal S; Jimenez-Castilla L; Prieto I; La Manna S; Gomez-Lopez S; Blanco-Colio LM; Egido J; Martin-Ventura JL; Gomez-Guerrero C
Clin Transl Med; 2021 Jul; 11(7):e463. PubMed ID: 34323424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
